Insights On China

[section class=”toup” padding=”0px”]

[ux_banner height=”580px” bg=”696″ bg_pos=”0% 15%”]

[text_box width=”51″ width__sm=”60″ scale=”198″ position_x=”5″ position_y=”90″ text_align=”left”]

INSIGHTS
ON China

CHINA HAS THE FASTEST GROWING HEALTHCARE MARKET

In China, aging populations, favorable regulations, healthcare innovations and growing demand for better healthcare are stimulating continuing growth of the market. Recent CFDA updates and new outbound investment regulations make now the best time to raise funds in China and enter the Chinese market.

[/text_box]

[/ux_banner]

[/section]
[section class=”moveupto” padding=”0px”]

[row width=”custom” custom_width=”90%” v_align=”equal” h_align=”center”]

[col span__sm=”12″ align=”center”]

[ux_image id=”853″ width=”84″]

[/col]

[/row]

[/section]
[section]

[row width=”custom” custom_width=”90%” v_align=”equal” h_align=”center”]

[col span__sm=”12″]

LATEST DEVELOPMENTS FROM CHINA

[/col]

[/row]
[row width=”custom” custom_width=”90%” v_align=”equal” h_align=”center”]

[col span=”2″ span__sm=”6″ align=”center”]

[/col]
[col span=”2″ span__sm=”6″ align=”center”]

[/col]
[col span=”2″ span__sm=”6″ align=”center”]

[/col]

[/row]

[/section]
[section]

[row style=”small” v_align=”equal” h_align=”center”]

[col span=”3″ span__sm=”6″]

[ux_image id=”627″]

[/col]
[col span=”3″ span__sm=”6″ padding=”0px 10px 0px 0px”]

China drafts new rule to improve management of outbound investment

BEIJING, Nov. 3 (Xinhua) — China’s top regulatory changes economic planner Friday released a new draft rule to simplify administrative procedures and strengthen regulation on outbound investment by Chinese firms…
READ MORE >>

[/col]
[col span=”3″ span__sm=”6″]

[ux_image id=”629″]

[/col]
[col span=”3″ span__sm=”6″]

Chinese Government Initiates Significant Drug and Device Regulatory Reforms

China has recently announced several initiatives to reform its regulation of drugs and medical devices that could …
READ MORE >>

[/col]

[/row]
[gap]

[row style=”small” v_align=”equal” h_align=”center”]

[col span=”3″ span__sm=”6″]

[ux_image id=”630″]

[/col]
[col span=”3″ span__sm=”6″ padding=”0px 10px 0px 0px”]

China’s NDRC seeks public comments on important outbound investment regulatory changes

On 3 November 2017, the National Development and Reform Commission (“NDRC”), one of China’s key outbound…
READ MORE >>

[/col]
[col span=”3″ span__sm=”6″]

[ux_image id=”628″]

[/col]
[col span=”3″ span__sm=”6″]

As National Party Congress concludes, China’s FDA seeks to write widely-anticipated drug reforms into law

In a bid to move Chinese drug industry regulations closer to the US/European model, …
READ MORE >>

[/col]

[/row]
[gap]

[row style=”small” v_align=”equal” h_align=”center”]

[col span=”3″ span__sm=”6″]

[ux_image id=”629″]

[/col]
[col span=”3″ span__sm=”6″ padding=”0px 10px 0px 0px”]

Excellence in Medical Affair: Recent trends in China Medical Affairs and Outcomes from China Medical Affairs Survey 2016

Excellence in Medical Affair: Recent trends in China Medical Affairs and Outcomes from China Medical Affairs Survey 2016″ is developed by Deloitte..
READ MORE >>

[/col]
[col span=”3″ span__sm=”6″]

[ux_image id=”627″]

[/col]
[col span=”3″ span__sm=”6″]

China’s changing pharmaceutical E-commerce market

“China’s changing pharmaceutical E- commerce market” is developed by Deloitte China Life Sciences and Health Care Industry, Technology, Media & Telecommunications Industry…
READ MORE >>

[/col]

[/row]
[gap height=”12px”]

[row width=”custom” custom_width=”90%” v_align=”equal” h_align=”center”]

[col span__sm=”12″ visibility=”hidden” align=”center”]

[/col]

[/row]

[/section]
[section]

[ux_banner height=”200px” bg=”698″]

[text_box width=”35″ width__sm=”60″ position_x=”5″ position_y=”50″ text_align=”left”]

Start selling your pharmaceutical
or medical device product in China.

[/text_box]

[/ux_banner]

[/section]